Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)

Study ID: NCT05269160
Start Date: 2023-04-24
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

37

Intervention / Treatment

Dermaprazole 1%

Dermaprazole 2%

Sponsor

Michelle S Ludwig

Source: clinicaltrials.gov

Share:
Add to list

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

Study ID: NCT04676360
Start Date: 2021-07-01
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Mafodotin Belantamab

Sponsor

Jacob Soumera, MD

Source: clinicaltrials.gov

Share:
Add to list

Lung EpiCheck Biomarkers Development Study

Study ID: NCT06245876
Start Date: 2022-05-17
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

6000

Intervention / Treatment

Blood collection

Sponsor

Nucleix Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses

Study ID: NCT05923060
Start Date: 2024-08-25
End Date: 2025-05-22
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Topical Aminolevulinate

Photodynamic therapy (PDT)

Red light illumination

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Study ID: NCT05983276
Start Date: 2023-11-16
End Date: 2031-08-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Decitabine

Carboplatin

Paclitaxel

Selinexor

Sponsor

Loyola University

Source: clinicaltrials.gov

Share:
Add to list

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Study ID: NCT06239194
Start Date: 2024-06-12
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

115

Intervention / Treatment

MDX2001

Sponsor

ModeX Therapeutics, An OPKO Health Company

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Efficacy and Safety of Light Dose in Subjects with PWB Treated with Hemoporfin PDT

Study ID: NCT05171894
Start Date: 2024-09-21
End Date: 2026-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

84

Intervention / Treatment

Hemopfin+Green Light

Vehicle+Green Light

Sponsor

Shanghai F U Egg-Zhang will bio-pharmaceutical co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Study ID: NCT06253494
Start Date: 2024-05-14
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

AdHER2DC vaccine

Pembrolizumab

N-803

Lenvew

PATHWAY HER2 (4B5) assay

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Study ID: NCT05226494
Start Date: 2022-06-23
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

34

Intervention / Treatment

fb-PMT

Sponsor

NanoPharmaceuticals LLC

Source: clinicaltrials.gov

Share:
Add to list

Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers

Study ID: NCT05596760
Start Date: 2023-09-11
End Date: 2027-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

Jumpstart Guide

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list